Author Archive

Trade Sale of Römergarten Senioren-Residenzen

Frankfurt am Main, September 2021. ACXIT Capital Partners acted as the exclusive M&A and financial advisor to the shareholders on the trade sale of Römergarten Senioren-Residenzen GmbH, a high-quality operator of elderly care facilities, to Domidep a portfolio company of the global infrastructure investment manager I Squared Capital.

Continue Reading

Successful rights issue of Meyer Burger Technology Ltd – 98.9% of subscription rights exercised

Frankfurt am Main, 24 July 2020. Meyer Burger Technology Ltd (SIX Swiss Exchange: MBTN) has announced on 22 July 2020 that 98.9% of the subscription rights have been exercised until the end of the subscription period on 22 July 2020, 12:00 CEST. In total, 1,272,465,688 new registered shares were offered to existing shareholders at a subscription price of CHF 0.09 per share. The 13,718,276 new registered shares to be issued, for which the subscription rights have not been exercised, will be sold on the market. The rights issue will thus generate gross proceeds of around CHF 115 Million.

Continue Reading

Zur Rose Group AG successfully completes CHF 212 million capital increase

Frankfurt am Main, 17 July 2020. Zur Rose Group AG (the “Company” or “Zur Rose Group”) successfully completed the capital increase that was resolved yesterday. A total of 740,823 new shares were sold in an international private placement to institutional investors at a placement price of CHF 287.00 per new share (the “Placement Price”).

Continue Reading

Zur Rose Group acquires TeleClinic, Germany’s leading telemedicine provider

Frankfurt am Main, 17 July 2020.

From diagnosis to delivery
Telemedicine pioneer TeleClinic offering reimbursable consultation services compliant with German national health insurance scheme
TeleClinic continuously expanding its time to market lead in the post-COVID-19 time
Telemedicine to form an important element in Zur Rose healthcare ecosystem, serving as additional entry point for digital customer journey
Doctors are given the opportunity to offer their expertise more flexible and independent of location
Both companies’ core businesses are further strengthened through highly complementary competencies with regard to the electronic prescription (eRx)

Continue Reading

ACXIT Capital Partners strengthens its financial sponsor coverage with Lars T. Rückert, Managing Director

Frankfurt am Main, 08 July 2020. ACXIT Capital Partners, a leading independent European corporate finance and financial advisory firm, is pleased to announce the addition of senior banker Lars T. Rückert to its financial sponsor practice. He is one of the bespoken industry experts in this field with profound understanding of corporate finance, M&A and capital markets as well as special experience in portfolio company management in the consumer/retail and e-commerce sector.

Continue Reading

ACXIT Capital Partners advised Zur Rose Group on the successful placement of CHF 175M Convertible Bonds

Frankfurt, 30 March 2020. Zur Rose Group AG (the “Company” or “Zur Rose”), via its subsidiary Zur Rose Finance B.V. (the “Issuer”), successfully completed the placement of senior unsecured bonds due 2025 (the “Bonds”), guaranteed by the Company and convertible into registered shares of the Company (the “Shares”).

Continue Reading